153 related articles for article (PubMed ID: 16153636)
1. Subchronic milnacipran treatment increases basal extracellular noradrenaline concentrations in the medial prefrontal cortex of rats.
Kitaichi Y; Inoue T; Izumi T; Nakagawa S; Kato A; Koyama T
Eur J Pharmacol; 2005 Sep; 520(1-3):37-42. PubMed ID: 16153636
[TBL] [Abstract][Full Text] [Related]
2. Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium.
Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T
Eur J Pharmacol; 2005 Jun; 516(3):219-26. PubMed ID: 15963494
[TBL] [Abstract][Full Text] [Related]
3. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T
Eur J Pharmacol; 2006 Feb; 532(3):236-45. PubMed ID: 16487506
[TBL] [Abstract][Full Text] [Related]
4. Effect of co-administration of lithium and reboxetine on extracellular monoamine concentrations in rats.
Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T
Eur J Pharmacol; 2004 Apr; 489(3):187-91. PubMed ID: 15087241
[TBL] [Abstract][Full Text] [Related]
5. A combination of mirtazapine and milnacipran augments the extracellular levels of monoamines in the rat brain.
Yamauchi M; Imanishi T; Koyama T
Neuropharmacology; 2012 Jun; 62(7):2278-87. PubMed ID: 22342987
[TBL] [Abstract][Full Text] [Related]
6. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
Devoto P; Flore G; Pira L; Longu G; Gessa GL
Eur J Pharmacol; 2004 Mar; 487(1-3):105-11. PubMed ID: 15033381
[TBL] [Abstract][Full Text] [Related]
7. Effect of co-administration of a serotonin-noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in rats.
Kitaichi Y; Inoue T; Izumi T; Nakagawa S; Tanaka T; Masui T; Koyama T
Eur J Pharmacol; 2008 Apr; 584(2-3):285-90. PubMed ID: 18336812
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine.
Kitaichi Y; Inoue T; Nakagawa S; Boku S; Izumi T; Koyama T
Eur J Pharmacol; 2010 Jul; 637(1-3):77-82. PubMed ID: 20406628
[TBL] [Abstract][Full Text] [Related]
9. Effect of zotepine on dopamine, serotonin and noradrenaline release in rat prefrontal cortex.
Nakamura S; Ago Y; Itoh S; Koyama Y; Baba A; Matsuda T
Eur J Pharmacol; 2005 Dec; 528(1-3):95-8. PubMed ID: 16321379
[TBL] [Abstract][Full Text] [Related]
10. Effect of long-term administration of the antidepressant drug milnacipran on serotonergic and noradrenergic neurotransmission in the rat hippocampus.
Weiss M; Blier P; de Montigny C
Life Sci; 2007 Jun; 81(2):166-76. PubMed ID: 17568622
[TBL] [Abstract][Full Text] [Related]
11. The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex.
Pira L; Mongeau R; Pani L
Eur J Pharmacol; 2004 Nov; 504(1-2):61-4. PubMed ID: 15507222
[TBL] [Abstract][Full Text] [Related]
12. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex.
Page ME; Lucki I
Neuropsychopharmacology; 2002 Aug; 27(2):237-47. PubMed ID: 12093597
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
[TBL] [Abstract][Full Text] [Related]
14. Effects of imipramine on extracellular serotonin and noradrenaline concentrations in ACTH-treated rats.
Kitamura Y; Akiyama K; Hashimoto S; Kitagawa K; Kawasaki H; Shibata K; Shinomiya K; Suemaru K; Araki H; Sendo T; Gomita Y
Eur J Pharmacol; 2007 Jul; 566(1-3):113-6. PubMed ID: 17459373
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex.
Devoto P; Flore G; Saba P; Fà M; Gessa GL
J Neurochem; 2005 Jan; 92(2):368-74. PubMed ID: 15663484
[TBL] [Abstract][Full Text] [Related]
16. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
[TBL] [Abstract][Full Text] [Related]
17. Effect of triiodothyronine (T(3)) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats.
Kitaichi Y; Inoue T; Nakagawa S; Boku S; Kato A; Kusumi I; Koyama T
Neuropsychiatr Dis Treat; 2012; 8():501-7. PubMed ID: 23139627
[TBL] [Abstract][Full Text] [Related]
18. Milnacipran enhances the control of impulsive action by activating D₁-like receptors in the infralimbic cortex.
Tsutsui-Kimura I; Ohmura Y; Izumi T; Kumamoto H; Yamaguchi T; Yoshida T; Yoshioka M
Psychopharmacology (Berl); 2013 Jan; 225(2):495-504. PubMed ID: 22892727
[TBL] [Abstract][Full Text] [Related]
19. Milnacipran attenuates hyperalgesia and potentiates antihyperalgesic effect of tramadol in rats with mononeuropathic pain.
Onal A; Parlar A; Ulker S
Pharmacol Biochem Behav; 2007 Dec; 88(2):171-8. PubMed ID: 17854875
[TBL] [Abstract][Full Text] [Related]
20. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
